Cipher Pharmaceuticals Inc (CPH) — Capital Reinvestment Ratio
Cipher Pharmaceuticals Inc (CPH) has a Capital Reinvestment Ratio of 0.01x as of June 2026, meaning it reinvests 0% of its operating cash flow (CA$2.98 Million) in capital expenditures (CA$15.52K). Check tangible net worth ratio of Cipher Pharmaceuticals Inc to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Cipher Pharmaceuticals Inc Capital Reinvestment Ratio (2010–2025)
This chart tracks Cipher Pharmaceuticals Inc's Capital Reinvestment Ratio across 14 annual periods. For the full cash flow conversion analysis, see how efficiently does Cipher Pharmaceuticals Inc generate cash.
Annual Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc (2010–2025)
Year-by-year Capital Reinvestment Ratio for Cipher Pharmaceuticals Inc from 2010 to 2025. See CPH FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | CA$30.25 Million | CA$28.49K | ▼ -58.2% |
| 2024 | 0.00x | CA$19.55 Million | CA$44.00K | ▼ -75.0% |
| 2023 | 0.01x | CA$16.00 Million | CA$144.00K | ▲ +17.5% |
| 2022 | 0.01x | CA$10.57 Million | CA$81.00K | ▲ +30.6% |
| 2021 | 0.01x | CA$13.81 Million | CA$81.00K | ▼ -91.0% |
| 2020 | 0.07x | CA$11.69 Million | CA$760.00K | ▼ -56.1% |
| 2019 | 0.15x | CA$8.86 Million | CA$1.31 Million | ▼ -74.8% |
| 2018 | 0.59x | CA$11.28 Million | CA$6.63 Million | ▲ +5695.3% |
| 2017 | 0.01x | CA$19.93 Million | CA$202.00K | ▼ -81.6% |
| 2016 | 0.06x | CA$11.47 Million | CA$632.00K | ▼ -94.3% |
| 2015 | 0.97x | CA$7.76 Million | CA$7.57 Million | ▲ +48456.0% |
| 2013 | 0.00x | CA$7.02 Million | CA$14.09K | ▼ -98.3% |
| 2012 | 0.12x | CA$6.90 Million | CA$795.11K | ▼ -80.5% |
| 2010 | 0.59x | CA$1.24 Million | CA$735.88K | — |